Global Aortic Stenosis Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Aortic Stenosis Market Research Report 2024
Aortic stenosis is a valvular heart disease with varying severity. Narrowed valve openings of the large blood vessel aorta reduce blow flow making the heart pump excessively. Poor prognosis with a fatal mortality rate is observed in severe cases. In-time diagnosis and treatment are of significant importance.
According to MRAResearch’s new survey, global Aortic Stenosis market is projected to reach US$ 10620 million in 2033, increasing from US$ 5398 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aortic Stenosis market research.
Key companies engaged in the Aortic Stenosis industry include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Aortic Stenosis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Aortic Stenosis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Aortic Stenosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Aortic Stenosis market is projected to reach US$ 10620 million in 2033, increasing from US$ 5398 million in 2022, with the CAGR of 10.0% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Aortic Stenosis market research.
Key companies engaged in the Aortic Stenosis industry include Abbott Laboratories, AstraZeneca Plc., Boston Scientific Corporation, Coroneo, CryoLife, Inc., Edwards Lifesciences Corporation, JenaValve Technology, Inc., LifeNet Health and LivaNova PLC, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Aortic Stenosis were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Aortic Stenosis market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Aortic Stenosis market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott Laboratories
AstraZeneca Plc.
Boston Scientific Corporation
Coroneo
CryoLife, Inc.
Edwards Lifesciences Corporation
JenaValve Technology, Inc.
LifeNet Health
LivaNova PLC
Medtronic Plc
Meril Life Sciences Pvt. Ltd.
Thubrikar Aortic Valve
Segment by Type
Transcatheter Aortic Valve Implantation (TAVI)
Surgical Aortic Valve Replacement (SAVR)
Segment by Application
Congenital Aortic Stenosis
Acquired Aortic Stenosis
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Aortic Stenosis report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source